De Baetselier; Patrick

Patent Applications and Registrations

Patent applications and USPTO patent grants for De Baetselier; Patrick.The latest application filed is for "immunoglobulin single variable domains directed against macrophage migration inhibitory factor".

Company Profile

0.12.12

De Baetselier; Patrick - Berchem BE
De Baetselier; Patrick - Antwerpen BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor Grant 11,098,113 - Vanlandschoot , et al. August 24, 2	2021-08-24
Immunoglobulin Single Variable Domains Directed Against Macrophage Migration Inhibitory Factor App 20190309056 - Vanlandschoot; Peter ; et al.	2019-10-10
Targeting and in vivo imaging of tumor-associated macrophages Grant 9,913,920 - Movahedi , et al. March 13, 2	2018-03-13
Method of imaging a cardiovascular disease with an anti-macrophage mannose receptor immunoglobulin single variable domain Grant 9,617,339 - De Baetselier , et al. April 11, 2	2017-04-11
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages Grant 9,556,273 - Van Ginderachter , et al. January 31, 2	2017-01-31
Anti-macrophage Mannose Receptor Single Variable Domains For Use In Cardiovascular Diseases App 20160024213 - De Baetselier; Patrick ; et al.	2016-01-28
Targeting And In Vivo Imaging Of Tumor-associated Macrophages App 20150335770 - Movahedi; Kiavash ; et al.	2015-11-26
Targeting and in vivo imaging of tumor-associated macrophages Grant 9,101,674 - Movahedi , et al. August 11, 2	2015-08-11
Anti-macrophage Mannose Receptor Single Variable Domains For Targeting And In Vivo Imaging Of Tumor-associated Macrophages App 20150093336 - Van Ginderachter; Jo ; et al.	2015-04-02
Targeting And In Vivo Imaging Of Tumor-associated Macrophages App 20120301394 - Movahedi; Kiavash ; et al.	2012-11-29
Selective targeting of intratumoral cells App 20110262348 - Movahedi; Kiavash ; et al.	2011-10-27
Novel Adipocytokine Visfatin/pbef1 Is An Apoptosis Associated Factor Induced In Monocytes During In Vivo Hiv-1 Infection App 20100184031 - Raes; Geert ; et al.	2010-07-22
Markers for alternatively activated macrophages Grant 7,514,217 - Raes , et al. April 7, 2	2009-04-07
TNF-derived peptides for use in treating oedema Grant 7,258,861 - Lucas , et al. August 21, 2	2007-08-21
Immunoconjugates App 20070031430 - Revets; Hilde ; et al.	2007-02-08
Peptides and nucleic acids derived from Eisenia foetida and the use thereof Grant 7,060,790 - de Baetselier , et al. June 13, 2	2006-06-13
Use of a polypeptide domain to modulate the tumorigenic and metastatic potential of cancer cells App 20060111294 - Revets; Hilde ; et al.	2006-05-25
Immunomodulatory protein derived from Trypanosomes and uses thereof App 20060002950 - De Baetselier; Patrick ; et al.	2006-01-05
Th1 inducing natural adjuvant for heterologous antigens Grant 6,936,263 - Revets , et al. August 30, 2	2005-08-30
Immunoconjugates App 20050048060 - Revets, Hilde ; et al.	2005-03-03
TNF-derived peptides for use in treating oedema App 20030105021 - Lucas, Rudolf ; et al.	2003-06-05
TNF-alpha muteins and a process for preparing them Grant 5,891,679 - Lucas , et al. April 6, 1	1999-04-06
Analytical utilization of phagocyte cell lines Grant 4,737,455 - De Baetselier April 12, 1	1988-04-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.